Possible Prediction of the Efficiency of Chemotherapy in Patients with Lymphoproliferative Diseases Based on MDR1 Gene G2677T and C3435T Polymorphisms

@article{Goreva2003PossiblePO,
  title={Possible Prediction of the Efficiency of Chemotherapy in Patients with Lymphoproliferative Diseases Based on MDR1 Gene G2677T and C3435T Polymorphisms},
  author={Olga Borisovna Goreva and Alevtina Yu. Grishanova and O. V. Mukhin and Natalia Domnikova and Vyacheslav V. Lyakhovich},
  journal={Bulletin of Experimental Biology and Medicine},
  year={2003},
  volume={136},
  pages={183-185}
}
Study of polymorphism in MDR1 gene exons 21 and 26 revealed that T2677T and T3435T alleles are not a factor predisposing to lymphoproliferative diseases, but they determine the efficiency chemotherapy. Individuals with T2677T and T3435T haplotypes are at highest risk of drug resistance. Association between genotypes G2677T and C3435T was detected in normal subjects and in patients with lymphoproliferative diseases. 

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.

Coupling of MDR1 Gene Polymorphisms in Positions 3435 and 2677 in Normal Subjects and Patients with Lymphoproliferative Diseases C/C3435

  • I. Cascorbi, T. Gerloff, A. Johne, Clin
  • Pharmacol. Ther.,
  • 2001

Similar Papers

Loading similar papers…